IL282523A - Aerosolisable formulation - Google Patents

Aerosolisable formulation

Info

Publication number: IL282523A
Authority: IL; Israel
Prior art keywords: aerosolisable formulation; aerosolisable; formulation
Prior art date: 2018-11-01

Application number

IL282523A

Other languages

Hebrew (he)

Original Assignee

Nicoventures Trading Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2018-11-01

Filing date

2021-04-21

Publication date

2021-06-30

2021-04-21 Application filed by Nicoventures Trading Ltd filed Critical Nicoventures Trading Ltd

2021-06-30 Publication of IL282523A publication Critical patent/IL282523A/en

Classifications

- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
- A24B15/10—Chemical features of tobacco products or tobacco substitutes
- A24B15/16—Chemical features of tobacco products or tobacco substitutes of tobacco substitutes
- A24B15/167—Chemical features of tobacco products or tobacco substitutes of tobacco substitutes in liquid or vaporisable form, e.g. liquid compositions for electronic cigarettes
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
- A24B15/18—Treatment of tobacco products or tobacco substitutes
- A24B15/24—Treatment of tobacco products or tobacco substitutes by extraction; Tobacco extracts
- A24B15/241—Extraction of specific substances
- A24B15/243—Nicotine
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
- A24B15/18—Treatment of tobacco products or tobacco substitutes
- A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
- A24B15/30—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
- A24B15/18—Treatment of tobacco products or tobacco substitutes
- A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
- A24B15/30—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances
- A24B15/32—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances by acyclic compounds
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24F—SMOKERS' REQUISITES; MATCH BOXES; SIMULATED SMOKING DEVICES
- A24F40/00—Electrically operated smoking devices; Component parts thereof; Manufacture thereof; Maintenance or testing thereof; Charging means specially adapted therefor
- A24F40/05—Devices without heating means
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24F—SMOKERS' REQUISITES; MATCH BOXES; SIMULATED SMOKING DEVICES
- A24F40/00—Electrically operated smoking devices; Component parts thereof; Manufacture thereof; Maintenance or testing thereof; Charging means specially adapted therefor
- A24F40/10—Devices using liquid inhalable precursors

Landscapes

Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Toxicology (AREA)
Medicinal Preparation (AREA)
General Preparation And Processing Of Foods (AREA)
Manufacture Of Tobacco Products (AREA)
Jellies, Jams, And Syrups (AREA)
Colloid Chemistry (AREA)

IL282523A 2018-11-01 2021-04-21 Aerosolisable formulation IL282523A (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB1817865.7A GB201817865D0 (en)	2018-11-01	2018-11-01	Aerosolisable formulation
PCT/GB2019/053092 WO2020089637A1 (en)	2018-11-01	2019-10-31	Aerosolisable formulation

Publications (1)

Publication Number	Publication Date
IL282523A true IL282523A (en)	2021-06-30

Family

ID=64655353

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL282523A IL282523A (en)	2018-11-01	2021-04-21	Aerosolisable formulation

Country Status (15)

Country	Link
US (1)	US20210386110A1 (en)
EP (2)	EP3873245B1 (en)
JP (1)	JP2022506094A (en)
KR (1)	KR102684717B1 (en)
CN (1)	CN113015444A (en)
AU (1)	AU2019371079B2 (en)
BR (1)	BR112021008556A2 (en)
CA (1)	CA3118051A1 (en)
ES (1)	ES2984536T3 (en)
GB (1)	GB201817865D0 (en)
IL (1)	IL282523A (en)
MX (1)	MX2021005123A (en)
PL (1)	PL3873245T3 (en)
UA (1)	UA128040C2 (en)
WO (1)	WO2020089637A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB201817859D0 (en) *	2018-11-01	2018-12-19	Nicoventures Trading Ltd	Aerosolisable formulation
GB202013489D0 (en)	2020-08-27	2020-10-14	Nicoventures Holdings Ltd	Consumable
US11771132B2 (en)	2020-08-27	2023-10-03	Rai Strategic Holdings, Inc.	Atomization nozzle for aerosol delivery device
US11771136B2 (en)	2020-09-28	2023-10-03	Rai Strategic Holdings, Inc.	Aerosol delivery device
IT202100022172A1 (en) *	2021-08-23	2023-02-23	Natural Acad S R L	MEDICAL LIQUID COMPOSITION FOR AIR ADMINISTRATION
KR20240028723A (en) *	2022-08-25	2024-03-05	주식회사 케이티앤지	Smoking articles including acids

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH0462094U (en) *	1990-10-09	1992-05-27
AU717600B2 (en) *	1993-07-26	2000-03-30	Mcneil Ab	Improved nicotine lozenge and therapeutic method for smoking cessation
US20080138399A1 (en) *	1999-07-16	2008-06-12	Aradigm Corporation	Dual release nicotine formulations, and systems and methods for their use
SE0104388D0 (en) *	2001-12-27	2001-12-27	Pharmacia Ab	New formulation and use and manufacture thereof
US20030159702A1 (en) *	2002-01-21	2003-08-28	Lindell Katarina E.A.	Formulation and use manufacture thereof
US7767698B2 (en) *	2002-06-03	2010-08-03	Mcneil Ab	Formulation and use thereof
HUP0500846A3 (en) *	2002-12-31	2008-10-28	Nektar Therapeutics	Pharmaceutical formulation with an insoluble active agent for pulmonary administration
SE0300520D0 (en) *	2003-02-28	2003-02-28	Pharmacia Ab	A container containing nicotine and its use and manufacture
US20070267033A1 (en) *	2006-02-09	2007-11-22	Philip Morris Usa Inc.	Gamma cyclodextrin flavoring-release additives
CN101583354A (en) *	2006-12-01	2009-11-18	阿拉迪姆公司	Systems for effecting cessation of tobacco use
GB0700889D0 (en) *	2007-01-17	2007-02-21	British American Tobacco Co	Tobacco, tobacco derivative and/or tobacco substitute products, preparation and uses thereof
US20080286340A1 (en) *	2007-05-16	2008-11-20	Sven-Borje Andersson	Buffered nicotine containing products
GB0918129D0 (en) *	2009-10-16	2009-12-02	British American Tobacco Co	Control of puff profile
US9333229B2 (en) *	2013-10-16	2016-05-10	William Bjorncrantz	Winterized crude cannabis extracts and methods of preparation and use
TWI664918B (en) *	2014-05-21	2019-07-11	瑞士商菲利浦莫里斯製品股份有限公司	Inductively heatable tobacco product
GB2528673B (en) *	2014-07-25	2020-07-01	Nicoventures Holdings Ltd	Aerosol provision system
GB201413835D0 (en) *	2014-08-05	2014-09-17	Nicoventures Holdings Ltd	Electronic vapour provision system
US20160198759A1 (en) *	2015-01-13	2016-07-14	Zip Llc	E-cigarette or vaping fluid
DE102015117811A1 (en) *	2015-10-20	2017-04-20	Chv Pharma Gmbh & Co. Kg	Inhaler and active ingredient-containing preparation for an inhaler
US20170325494A1 (en) *	2016-05-16	2017-11-16	Lunatech, Llc	Liquid composition containing nicotine from non-tobacco source for use with electronic vaporizing devices
US12114688B2 (en) *	2017-10-24	2024-10-15	Rai Strategic Holdings, Inc.	Method for formulating aerosol precursor for aerosol delivery device
GB2569940B (en) *	2017-11-01	2022-10-19	Nicoventures Trading Ltd	Aerosolisable formulation
EP3574902A1 (en) *	2018-06-01	2019-12-04	Yatzz Limited	Nicotine formulation and mode of delivery
GB201817859D0 (en) *	2018-11-01	2018-12-19	Nicoventures Trading Ltd	Aerosolisable formulation

2018
- 2018-11-01 GB GBGB1817865.7A patent/GB201817865D0/en not_active Ceased
2019
- 2019-10-31 UA UAA202102224A patent/UA128040C2/en unknown
- 2019-10-31 MX MX2021005123A patent/MX2021005123A/en unknown
- 2019-10-31 JP JP2021523256A patent/JP2022506094A/en active Pending
- 2019-10-31 WO PCT/GB2019/053092 patent/WO2020089637A1/en unknown
- 2019-10-31 BR BR112021008556-4A patent/BR112021008556A2/en unknown
- 2019-10-31 ES ES19798365T patent/ES2984536T3/en active Active
- 2019-10-31 CN CN201980075317.2A patent/CN113015444A/en active Pending
- 2019-10-31 PL PL19798365.3T patent/PL3873245T3/en unknown
- 2019-10-31 AU AU2019371079A patent/AU2019371079B2/en active Active
- 2019-10-31 US US17/290,319 patent/US20210386110A1/en active Pending
- 2019-10-31 KR KR1020217012916A patent/KR102684717B1/en active IP Right Grant
- 2019-10-31 EP EP19798365.3A patent/EP3873245B1/en active Active
- 2019-10-31 EP EP24152849.6A patent/EP4353091A3/en active Pending
- 2019-10-31 CA CA3118051A patent/CA3118051A1/en active Pending
2021
- 2021-04-21 IL IL282523A patent/IL282523A/en unknown

Also Published As

Publication number	Publication date
CN113015444A (en)	2021-06-22
AU2019371079A1 (en)	2021-05-27
CA3118051A1 (en)	2020-05-07
EP3873245A1 (en)	2021-09-08
GB201817865D0 (en)	2018-12-19
EP4353091A3 (en)	2024-07-10
MX2021005123A (en)	2021-06-15
BR112021008556A2 (en)	2021-08-03
UA128040C2 (en)	2024-03-20
KR20210075107A (en)	2021-06-22
WO2020089637A1 (en)	2020-05-07
PL3873245T3 (en)	2024-07-29
AU2019371079B2 (en)	2022-07-14
KR102684717B1 (en)	2024-07-11
US20210386110A1 (en)	2021-12-16
JP2022506094A (en)	2022-01-17
EP4353091A2 (en)	2024-04-17
EP3873245B1 (en)	2024-02-28
ES2984536T3 (en)	2024-10-29

Publication	Publication Date	Title
IL282617A (en)	2021-06-30	Aerosolisable formulation
IL274139A (en)	2020-06-30	Aerosolisable formulation
GB201801614D0 (en)	2018-03-14	Formulation
IL282523A (en)	2021-06-30	Aerosolisable formulation
IL282589A (en)	2021-06-30	Aerosolisable formulation
IL282567A (en)	2021-06-30	Aerosolisable formulation
GB201816447D0 (en)	2018-11-28	Formulation
IL282461A (en)	2021-06-30	Aerosolisable formulation
IL282392A (en)	2021-06-30	Aerosolisable formulation
IL274719A (en)	2020-07-30	Formulation
IL282697A (en)	2021-06-30	Aerosolisable formulation
IL284688A (en)	2021-08-31	Formulation
GB201706969D0 (en)	2017-06-14	Formulation
GB201807312D0 (en)	2018-06-20	Formulation
IL280138A (en)	2021-03-01	Aerosolisable formulation
GB201913232D0 (en)	2019-10-30	Aerosolisable formulation
GB201813229D0 (en)	2018-09-26	Formulation
GB201719464D0 (en)	2018-01-10	Formulation
EP3768322C0 (en)	2024-07-31	Formulation
GB2587402B (en)	2023-05-10	Formulation
GB201817866D0 (en)	2018-12-19	Aerosolisable formulation
GB201809575D0 (en)	2018-07-25	Formulation
GB201906242D0 (en)	2019-06-19	Aerosolisable formulation
GB201900658D0 (en)	2019-03-06	Formulation
GB201806490D0 (en)	2018-06-06	Novel formulation